Yeah but everyone wants to be a Winner ;)
Printable View
My strategy is two fold: if
a) the price rises to punch through what I've just sold at (i.e. 149c), then I buy on the up, otherwise if
b) the price continues to fall as it is now, I buy in again where it looks like support is confirmed...in a few days time (after this report is more publically digested and no more news for a week or so brings with it less interest and hype).
BC
Following on from my "private sales" comment...
You have 70k new bladder cancer patients a year. In the time the lab was open that is about 10k patients diagnosed with bladder cancer... say one in ten actually did some research on the internet about their condition and found CxBladder (it would be hard to miss). Say only 1 in 10 went and ordered a test... that would still be ~100 tests and 50k in revenue. But I just saw - page 6 - two sold in the US. Hmmmm....
1/1000 is probably more accurate and look, that's about what we have. It's not like buying a pregnancy test and even then someone that thought they were pregnant would go to a doctor to get a proper check. Until it's offered and fully endorsed by doctors sales won't move dramatically. Consumers aren't self informed to that degree when it comes to medical care. If they were, everybody would be buying testing kits the minute any kind of self diagnosable issue arose instead of simply talking to their doctor and then (and this is key) taking their advice, not the internet.
First commercial sales in the USA were only announced in mid October. So nothing was ever going to appear in this report